« Back to Record
Van Laethem, J.-L., Melichar, B., Cascinu, S., Saramak, P., Michl, P., Van Brummelen, D., Zaniboni, A., Schmiegel, W., Dueland, S., Giurescu, M., Garosi, V. V., Riess, H., Roth, K., Schulz, A., Seidel, H., Rajagopalan, P., Teufel, M., Childs, B. B., Jassem, J., Haas, M., Martens, U. U., Weekes, C., Peeters, M., Ross, P., & Bridgewater, J. (2017). Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer. Targeted Oncology, 12(1), 97-109. doi:10.1007/s11523-016-0469-y
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/245726



